Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2023-11-15
2025-07-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma
NCT06145581
Yoga Intervention for Cancer Survivors
NCT01228955
Yoga for Solid Tumor
NCT03728205
Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer
NCT03220945
Technology-Assisted Yoga and Exercise on Neuropathy and Pain in Children With Leukemia
NCT06512012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate yoga group
20 participants randomized to immediate yoga intervention group will participate together in a weekly 40-minute guided mindful yoga intervention for a total of 12 consecutive weeks. After each session, participants will be asked to complete the Edmonton Symptom Assessment System (ESAS-r) through MyDataHelps app. At the end of each session, participants will be asked additional questions via MyDataHelps such as completion of yoga session on-site or remotely, the length of time they participated in the session, any additional yoga sessions during the past week, and comments regarding the session/intervention. These participants will also complete health-related quality of life (HRQOL) assessment (EORTC QLQ-C30) at baseline, 6 weeks, and 12 weeks during active yoga intervention.
Immediate yoga intervention
Subjects will complete 12 consecutive weeks of weekly 40 minute guided mindful yoga weeks 1-12.
Waitlist yoga group (delayed yoga intervention group)
20 participants randomized to this group will start the yoga intervention at week 13 and participate in 12 consecutive weeks of weekly 40 minute guided mindful yoga. Participants in this group will complete ESAS-r every 3 weeks and EORTC QLQ-C30 every 6 weeks for the first 12 weeks. These participants will also complete HRQOL assessment (EORTC QLQ-C30) at baseline, 6 weeks, and 12 weeks during active yoga intervention, weeks 13-24.
Delayed yoga intervention
Subjects will complete 12 consecutive weeks of weekly 40 minute guided mindful yoga weeks 13-24.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate yoga intervention
Subjects will complete 12 consecutive weeks of weekly 40 minute guided mindful yoga weeks 1-12.
Delayed yoga intervention
Subjects will complete 12 consecutive weeks of weekly 40 minute guided mindful yoga weeks 13-24.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand basic English
* Able to provide informed consent
* Diagnosis of multiple myeloma on active treatment as determined by investigators
* Good performance status as defined by European Cooperative Oncology Group score 0-1
* Able to utilize computer/laptop and smart phone
* Able and willing to travel to the yoga studio for weekly sessions
* Able to utilized a wearable device, such as Apple Watch or Fitbit (optional)
Exclusion Criteria
* Actively participating in another clinical trial
* Poorly controlled mental health symptoms as determined by treating physician
* Reported fall or syncope in the last 2 months prior to enrollment
* Concurrent diagnosis of amyloidosis or other cancer requiring active treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shaunak Pandya, MD
Role: PRINCIPAL_INVESTIGATOR
University of Arizona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona Cancer Center
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00003083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.